Lara Danziger-Isakov

Lara Danziger-Isakov

Auto-generated profile, based on publicly available information

Lara Danziger-Isakov

Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
LDLara Danziger‐Isakov
Lara Danziger‐Isakov
DKDeepali Kumar
Deepali Kumar
TPThe AST ID Community of Practice
The AST ID Community of Practice

1 February 2022 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
AAAkansha Agrawal
Akansha Agrawal
MIMichael G. Ison
Michael G. Ison
LDLara Danziger-Isakov
Lara Danziger-Isakov
Infections remain a common complication of solid-organ transplantation. Most infections in the first month after transplant are typically health care–associated infections, whereas late infections, beyond 6–12 months, are community-acquired infections. Opportunistic infections most frequently present in the first 12 months post-transplant and can be modulated on prior exposures and use of prophylaxis. In this review, we summarize the current epidemiology of postkidney transplant infections with a focus on key viral (BK polyomavirus, cytomegalovirus, Epstein-Barr virus, and norovirus), bacterial (urinary tract infections and Clostridioides difficile colitis), and fungal infections. Current guidelines for safe living post-transplant are also summarized. Literature supporting prophylaxis and vaccination is also provided.

30 December 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
MMMarian G. Michaels
Marian G. Michaels
RHRicardo M. La Hoz
Ricardo M. La Hoz
LDLara Danziger-Isakov
Lara Danziger-Isakov
EBEmily A. Blumberg
Emily A. Blumberg
DKDeepali Kumar
Deepali Kumar
CWCameron R. Wolfe
Cameron R. Wolfe
The recent identification of an outbreak of 2019- novel Coronavirus is currently evolving, and the impact on transplantation is unknown. However, it is imperative that we anticipate the potential impact on the transplant community in order to avert severe consequences of this infection on both the transplant community and contacts of transplant patients.

30 December 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
LDLara Danziger-Isakov
Lara Danziger-Isakov
EBEmily A. Blumberg
Emily A. Blumberg
OMOriol Manuel
Oriol Manuel
MSMartina Sester
Martina Sester
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early 2020. The impact on solid organ transplantation (SOT) has been profound affecting potential donors, candidates, and recipients. Importantly, decreased donations and the pressure of limited resources placed on health care by the pandemic also disrupted transplant systems. We address the impact of COVID-19 on organ transplantation globally and review current understanding of the epidemiology, outcomes, diagnosis, and treatment of COVID-19 in SOT recipients.

9 September 2019 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
SSSneha Suresh
Sneha Suresh
JUJulia Upton
Julia Upton
MGMichael Green
Michael Green
APAnne Pham‐Huy
Anne Pham‐Huy
KPKlara M. Posfay‐Barbe
Klara M. Posfay‐Barbe
UAUpton D. Allen
Upton D. Allen

29 October 2017 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
JBJoshua A. Blatter
Joshua A. Blatter
SSStuart C. Sweet
Stuart C. Sweet
CCCarol Conrad
Carol Conrad
LDLara A. Danziger‐Isakov
Lara A. Danziger‐Isakov
AFAlbert Faro
Albert Faro
DWDavid Wang
David Wang